Latest Breaking News On - Kosj yamoah - Page 4 : comparemela.com

 E-Mail TAMPA, Fla. Prostate cancer is one of the most common cancers among men in the United States. One in nine men will be diagnosed during his lifetime. When diagnosed, a patient s disease is graded from 1 to 5 based on how aggressive it is, with 5 being the most aggressive. Those with grades 4/5 disease are at the highest risk of poor outcomes or death from the disease; however, there are no immunologic or genomic indicators that can help physicians determine the best course of treatment for this group of patients. Moffitt Cancer Center researchers, led by Kosj Yamoah, M.D., Ph.D., associate member and director of cancer disparities research in the departments of Radiation Oncology and Cancer Epidemiology, are hoping to change that. The team conducted studies to determine if genomic heterogeneity in tumors from grade 4/5 prostate cancer patients can be exploited to identify patient subsets that are at higher risk for lethal outcomes and that may benefit from targeted treatm

United statesKosj yamoahDepartment of defenseProstate cancer foundationMoffitt cancer centerCancer centerRadiation oncologyCancer epidemiologyDecipher genomics resource information databaseஒன்றுபட்டது மாநிலங்களில்துறை ஆஃப் பாதுகாப்புப்ராஸ்டேட் புற்றுநோய் அடித்தளம்மாஃபிட் புற்றுநோய் மையம்புற்றுநோய் மையம்கதிர்வீச்சு புற்றுநோயியல்புற்றுநோய் தொற்றுநோய்